Abstract PR10: FBXO11 is recurrently mutated in Burkitt lymphoma and its inactivation accelerates lymphomagenesis in Eμ-myc mice

JOURNAL ARTICLE published 15 December 2017 in Clinical Cancer Research

Authors: Chiara Pighi | Mara Compagno | Taek-Chin Cheong | Teresa Poggio | Qi Wang | Fernanda Langellotto | Anoop Sendamarai | Kyriacos Markianos | Paola Francia di Celle | Alberto Zamò | Roberto Chiarle

Chimmitecan, a Novel 9-Substituted Camptothecin, with Improved Anticancer Pharmacologic Profiles In vitro and In vivo

JOURNAL ARTICLE published 15 February 2007 in Clinical Cancer Research

Authors: Min Huang | Heyong Gao | Yi Chen | Hong Zhu | Yujun Cai | Xiongwen Zhang | Zehong Miao | Hualiang Jiang | Jian Zhang | Hongwu Shen | Liping Lin | Wei Lu | Jian Ding

Involvement of Chemokine Receptor 4/Stromal Cell–Derived Factor 1 System during Osteosarcoma Tumor Progression

JOURNAL ARTICLE published 15 January 2005 in Clinical Cancer Research

Authors: Eliana Perissinotto | Giuliana Cavalloni | Francesco Leone | Valentina Fonsato | Stefania Mitola | Giovanni Grignani | Nadia Surrenti | Dario Sangiolo | Federico Bussolino | Wanda Piacibello | Massimo Aglietta

Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development

JOURNAL ARTICLE published 15 April 2009 in Clinical Cancer Research

Authors: Raisa Vuononvirta | Neil J. Sebire | Boo Messahel | Nina Perusinghe | Jorge S. Reis-Filho | Kathy Pritchard-Jones | Gordan M. Vujanic | Chris Jones

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

JOURNAL ARTICLE published 15 September 2021 in Clinical Cancer Research

Authors: Shannon L. Puhalla | Véronique Diéras | Banu K. Arun | Bella Kaufman | Hans Wildiers | Hyo S. Han | Jean-Pierre Ayoub | Vered Stearns | Yuan Yuan | Teresa Helsten | Bridget Riley-Gillis | Erin Murphy | Madan G. Kundu | Meijing Wu | David Maag | Christine K. Ratajczak | Cyril Y. Ramathal | Michael Friedlander

The Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Vatalanib and Pazopanib Potently Induce Apoptosis in Chronic Lymphocytic Leukemia Cells In vitro and In vivo

JOURNAL ARTICLE published 1 July 2010 in Clinical Cancer Research

Authors: Julian Paesler | Iris Gehrke | Rajesh Kumar Gandhirajan | Alexandra Filipovich | Magdalena Hertweck | Felix Erdfelder | Sabrina Uhrmacher | Simon Jonas Poll-Wolbeck | Michael Hallek | Karl-Anton Kreuzer

The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB

JOURNAL ARTICLE published 15 July 2017 in Clinical Cancer Research

Authors: Jose Manuel Garcia-Heredia | Antonio Lucena-Cacace | Eva M. Verdugo-Sivianes | Marco Pérez | Amancio Carnero

Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer

JOURNAL ARTICLE published 1 April 2022 in Clinical Cancer Research

Research funded by NCI University of Pittsburgh UPMC Hillman Cancer Center SPORE in Head and Neck Cancer (P50 CA097190) | of the UPMC Hillman Cancer Center Support (P30 CA047904)

Authors: Robert L. Ferris | Jessica Moskovitz | Sheryl Kunning | Ayana T. Ruffin | Carly Reeder | James Ohr | William E. Gooding | Seungwon Kim | Brian J. Karlovits | Dario A.A. Vignali | Umamaheswar Duvvuri | Jonas T. Johnson | Daniel Petro | Dwight E. Heron | David A. Clump | Tullia C. Bruno | Julie E. Bauman

Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic

JOURNAL ARTICLE published 15 September 2020 in Clinical Cancer Research

Authors: Heather A. Lankes | Mark A. Watson | Richard C. Jordan | Nilsa C. Ramirez | Ignacio I. Wistuba | Lois Shepherd | Irina A. Lubensky | Hala Makhlouf

Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial

JOURNAL ARTICLE published 17 January 2023 in Clinical Cancer Research

Authors: Daniel S. Green | Franklin Ning | Anna Duemler | Timothy G. Myers | Kathryn Trewhitt | Irene Ekwede | Ann McCoy | Nicole Houston | Jung-min Lee | Stanley Lipkowitz | Alexandra Zimmer | Miroslava Pavelova | Erin N. Villanueva | Leslie Smith | Andrew Blakely | Yovanni Casablanca | Steven L. Highfill | David F. Stroncek | Naoza Collins-Johnson | Sandhya Panch | JoLynn Procter | Chauha Pham | Soumya Korrapati | Steven M. Holland | Lindsey B. Rosen | Ana T. Nunes | Kathryn C. Zoon | Christopher B. Cole | Christina M. Annunziata

Twist of Fate for Acute Promyelocytic Leukemia: TRIB3–TWIST1 Interaction Promotes Resistance

JOURNAL ARTICLE published 15 October 2019 in Clinical Cancer Research

Research funded by NCI (R01 CA196973)

Authors: Stephen Z. Peeke | Kira Gritsman

Inevitable Progress—Relying on the Immune System, Not Chance

JOURNAL ARTICLE published 1 February 2022 in Clinical Cancer Research

Authors: Assuntina G. Sacco | Ezra E.W. Cohen

Diffusion-Weighted MRI for Lymphoma Staging—Response

JOURNAL ARTICLE published 1 January 2015 in Clinical Cancer Research

Authors: Marius E. Mayerhoefer | Markus Raderer

Prognostic Value of CD133 Caused by Mutant K-Ras and B-Raf—Response

JOURNAL ARTICLE published 15 August 2012 in Clinical Cancer Research

Authors: Kristel Kemper | Jan Paul Medema

Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer

JOURNAL ARTICLE published 15 February 2019 in Clinical Cancer Research

Authors: Luigi Formisano | Kimberly M. Stauffer | Christian D. Young | Neil E. Bhola | Angel L. Guerrero-Zotano | Valerie M. Jansen | Mónica M. Estrada | Katherine E. Hutchinson | Jennifer M. Giltnane | Luis J. Schwarz | Yao Lu | Justin M. Balko | Olivier Deas | Stefano Cairo | Jean-Gabriel Judde | Ingrid A. Mayer | Melinda Sanders | Teresa C. Dugger | Roberto Bianco | Thomas Stricker | Carlos L. Arteaga

Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors

JOURNAL ARTICLE published 15 February 2019 in Clinical Cancer Research

Authors: Sarah Croessmann | Jonathan H. Sheehan | Kyung-min Lee | Gregory Sliwoski | Jie He | Rebecca Nagy | David Riddle | Ingrid A. Mayer | Justin M. Balko | Richard Lanman | Vincent A. Miller | Lewis C. Cantley | Jens Meiler | Carlos L. Arteaga

Forestalling BRAF-Inhibitor Resistance in a Shocking Way

JOURNAL ARTICLE published 15 November 2018 in Clinical Cancer Research

Authors: Ryan J. Sullivan

Correction: ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy

JOURNAL ARTICLE published 1 April 2017 in Clinical Cancer Research

MET DNA Alterations in NSCLC—Reply

JOURNAL ARTICLE published 15 July 2016 in Clinical Cancer Research

Authors: Joanna H.M. Tong | Anthony W.H. Chan | Ka F. To

Plasma Tumor Mutation Burden and Response to Pembrolizumab—Letter

JOURNAL ARTICLE published 1 July 2020 in Clinical Cancer Research

Research funded by National Natural Science Foundation of China (81974361) | CAMS (2018-I2M-1-002)

Authors: Xiaoyan Li | Yu Xu | Guoqiang Wang | Lin Li